Lisa FLASSE - IREC/LTAPNew mechanistic insights into the adverse outcomes of low-toxicity persistent particlesMert Can YILDIRIM - TFAR/FACMAsymmetric Membrane Properties as Determinants of Antibiotic Permeation, Activity, and Bacterial AdaptationInfo: mireille.alhouayek@uclouvain.be 

Paul PARRENS – ADDBPeptide derivatives against intracellular S. aureus persisters: selecting lead compounds for future formulationElsa TEMPERMAN - BPBL The effect of endocannabinoid-derived prostaglandins and of ABHD6 inhibition in lung inflammationInfo: mireille.alhouayek@uclouvain.be 

Dr Bradley WARD - TFAR PMGK - Postdoctoral Researcher in Bioinformatics and Multi-Omics Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKineticsThe use and development of exploratory multi-omic analysis for complex disease: A COVID-19 Proof-of-conceptRelated publications:•    Ward B, Yombi JC, Balligand JL, Cani PD, Collet JF, de Greef J, Dewulf JP, Gatto L, Haufroid V

Wednesday April 22, 2026 – 4pm – Auditoire 51GChi-Hsien LEE – MNUTDiscovery of a novel myo-inositol to butyrate fermentation pathway and taxonomic expansion of the genus Dysosmobacter in the human gutPromotor: Prof.

Lorine LEMAIRE – ADDB and MITH (VUB)Design of an anti-elastase nanomedicine to prevent the evolution of emphysema in chronic obstructive pulmonary diseaseMarie-Sophie MARTOU – CMFA and IREC/FATHCreating anti-angiogenic miniproteins targeting protein-protein interactions as a new strategy in anticancer therapyInfo: mireille.alhouayek@uclouvain.be  

Prof.

Friday April 10, 2026 – 4:30 pm – Auditoire B (Auditoires centraux - 51 Av. E. Mounier - 1200 Bxl) Darius MAZHARI DOROOEE – CMFAStructural and mechanistic investigation of the acyl-CoA synthetase long-chain family member 4 (ACSL4) inhibition in the context of ferroptosis-related diseases and cancerPromotor: Prof.

Dr Evelyne VAN den BROUCKE - Pharmacy Department, University Hospitals Leuven - Advancing Pharmacist-Led Services for Optimised Pharmacotherapy Expanding the Check of Medication Appropriateness (CMA), Developing the Check of Compounding Appropriateness (CCA) & Establishing a Centre for Medicines Information (CMI)Related publications:•    Evaluation and implementation o

Eloïse VIERA OLIVERA – MNUTInterest of volatilome analysis in the eludication of gut microbiota – host interactions in nutrition and healthProm: Prof. Nathalie DelzenneDaria KOVRYZHENKO - TFAR FACMMembrane properties upon aggressiveness and invasiveness of glioblastoma cells in relation to mechanosensationProm: Prof. Joseph LorentInfo: mireille.alhouayek@uclouvain.be  

Seminar organized on the occasion of the 2025 Medecine Nobel PrizeProf. Sophie LUCAS - Institut de Duve – UCLouvainRegulatory T Cells in the Spotlight: From Nobel Discoveries in Immune Tolerance to Emerging Strategies in Cancer Immunotherapy Info: didier.lambert@uclouvain.be